MedPath

PRG Combined With Autologous BMMSCs for Treatment of Diabetic Foot Ulcer

Early Phase 1
Conditions
Diabetic Foot Ulcer
Interventions
Biological: PRG combined with BMMSCs transplantation
Registration Number
NCT03248466
Lead Sponsor
Third Military Medical University
Brief Summary

To investigate the treatment effect between Traditional treatment and transplantation of autologous PRG combined with autologous BMMSCs for treatment of diabetic foot ulcer.

Detailed Description

60 diabetic foot ulcer in our hospital will divide into 3 groups: group A (20 diabetic foot ulcer who give Traditional treatment), group B (20 diabetic foot ulcer who give Traditional treatment and transplantation of autologous platelet rich gel),group C (20 diabetic foot ulcer who give Traditional treatment and transplantation of autologous platelet rich gel combined with autologous bone marrow mesenchymal stem cells). The age, height, weight, blood glucose, glycosylated hemoglobin A1c(HbA1c), lipid, blood pressure, course of disease, Wound healing rate,transcutaneous oxygen pressure,Amputation rate,Hospital stay will record respectively. And High-sensitive C-reactive protein (HsCRP) and Tumor necrosis factor-α(TNF-α) will detect as Baseline. After each group's treatment, Change from baseline of all indexes will record, one way Analysis of Variance will be analyzed the significantion among 3 groups.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Diabetic foot according to The Wagner is 2-3 graded;
Exclusion Criteria
  • Type 1 diabetes mellitus,presence of autoimmune diabetes;
  • Gestational diabetes;
  • Patients with heart, liver, or renal function impairment;presence of severe infections or cerebrovascular disease.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PRG combined with BMMSCs transplantationPRG combined with BMMSCs transplantationTraditional treatment such as insulin,antidiabetes,dressing and Autologous PRG combined with BMMSCs
Traditional treatmentPRG combined with BMMSCs transplantationTraditional treatment such as insulin,antidiabetes,dressing
Primary Outcome Measures
NameTimeMethod
Amputation rateup to 6 months

Amputation rate up to 6 months

hospital stayup to 6 months

hospital stay

Secondary Outcome Measures
NameTimeMethod
Wound healing timeup to 6 months

Wound healing time

Transcutaneous oxygen partial pressureTranscutaneous oxygen partial pressure up to 6 months

Transcutaneous oxygen partial pressure

Trial Locations

Locations (2)

Southwest Hospital of the Third Military Medical University

🇨🇳

Chongqing, Chongqing, China

Endocrine Department, the First Affiliated Hospital of the Third Military Medical University

🇨🇳

Chongqing, Chongqing, China

© Copyright 2025. All Rights Reserved by MedPath